Tessella. Complex problems. Solved.

Posts Tagged ‘Clinical Technologies’

Optimising Drug Development Plans – On Demand Webinar

Friday, December 21st, 2012

Join Tom Parke to learn more about using clinical trial simulations and calculations of expected net present value (eNPV) to optimise development decisions and trial designs. Two examples of simulating and optimising drug development plans are presented — 1. DIA Adaptive Program (Oncology sub-stream), looking at the problem of how best to develop two candidate [...]

Bio-IT World: Adaptive Study Design May Become Survival Tactic

In the not-so-distant future, the pharmaceutical industry will need to move away from serendipity and its “blockbuster” drug development approach to become a service-based business specializing in patient-specific therapeutics delivering desired outcomes at the desired price. Clinical trials, of necessity, will be re-engineered to reflect real-world circumstances and turn adaptive study programs into a competitive [...]

Pharmaceutical Business Review: PPD to use Tessella and Berry Consultants adaptive trial design solution

Pharmaceutical Product Development (PPD) has entered into a license agreement to use Tessella and Berry Consultants’ adaptive trial design solution…read more

Webinar – How simulation can be used to optimize drug development programmes, Wednesday December 12th, 2012

Thursday, November 15th, 2012

You are invited to join Tom Parke to learn more about using clinical trial simulations and calculations of expected net present value (eNPV) to optimise development decisions and trial designs. Abstract: Two examples of simulating and optimising drug development plans will be presented – 1. DIA Adaptive Program (Oncology sub-stream), looking at the problem of [...]

Press release: PPD Signs Agreement to Use Tessella and Berry Consultants’ Adaptive Trial Design Software

FACTSTM software enhances PPD’s ability to deliver time- and cost-savings for clients WILMINGTON, N.C., and NEWTON, Mass. (November 14, 2012) – Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials. The software [...]

Tessella and Neusentis, a research unit of Pfizer Limited, Team Recognised for Innovative Data Analysis Technique

Tuesday, October 9th, 2012

Novel work analysing microneurography data wins Tessella Excellence Award A Tessella project, working with a team of Neusentis scientists from Cambridge and other Pfizer scientists from Sandwich, respectively, has been recognised for novel work analysing microneurography data with a Tessella Excellence Award in the ‘Most Innovative Work’ category. The Tessella Excellence Awards were created to [...]

Press release: Delivering Innovation and Efficiency through Adaptive Clinical Trials

Aptiv Solutions, Berry Consultants and Tessella have partnered together to develop a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess their potential for transforming drug development. Join experts in the economics and management of the pharmaceutical industry, drug developers, and adaptive [...]

Press release: Designing Enrichment Studies in Personalised Medicine – Free Webinar

Kert Viele describes how simulation can help you overcome the challenges of designing enrichment studies in personalized medicine Oxford, UK | 17th September 2012. Tessella, the international provider of science powered technology and consulting services, is hosting a free online webinar, first of an Autumn series, for all life sciences professionals interested in deepening their [...]

Free webinar – Optimising Drug Development: Enabling Quantitative Decision Making Through Simulation

Wednesday, February 29th, 2012

Watch on youtube In this webinar Tom Parke discusses key questions about the use of quantitative decision making in drug development through simulation including: How can simulations of drug response be used to design a trial? With so many issues, including sub-population analysis, comparative effectiveness and testing drugs in combination, how can you decide what [...]

Aptiv Solutions, the first CRO to license Tessella and Berry Consultants FACTS technology

Tuesday, February 28th, 2012

Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services and Berry Consultants, leaders in the Bayesian approach to medical statistics, to deliver integrated early [...]